Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1404

1.

Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions - a review with a systematic approach.

Morath B, Mayer T, Send AFJ, Hoppe-Tichy T, Haefeli WE, Seidling HM.

Br J Clin Pharmacol. 2017 Apr 27. doi: 10.1111/bcp.13318. [Epub ahead of print] Review.

PMID:
28452063
2.

Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.

Molteni M, Bo M, Di Minno G, Di Pasquale G, Genovesi S, Toni D, Verdecchia P.

Intern Emerg Med. 2017 Apr 24. doi: 10.1007/s11739-017-1660-6. [Epub ahead of print] Review.

PMID:
28439778
3.
4.

Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review.

Patel R, Charles S, Jalil A.

Graefes Arch Clin Exp Ophthalmol. 2017 Apr 18. doi: 10.1007/s00417-017-3664-3. [Epub ahead of print] Review.

PMID:
28421343
5.

Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.

Ayalasomayajula S, Langenickel T, Pal P, Boggarapu S, Sunkara G.

Clin Pharmacokinet. 2017 Apr 17. doi: 10.1007/s40262-017-0543-3. [Epub ahead of print] Review.

PMID:
28417439
6.

Pharmacological secondary prevention in patients with mesenterial artery atherosclerosis and arterial embolism.

Gottsäter A.

Best Pract Res Clin Gastroenterol. 2017 Feb;31(1):105-109. doi: 10.1016/j.bpg.2016.07.004. Epub 2016 Jul 28. Review.

PMID:
28395781
7.

Direct Oral Anticoagulants in the Treatment of Venous Thromboembolic Disease.

Salmerón Febres LM, Cuenca Manteca J.

Ann Vasc Surg. 2017 Apr 5. pii: S0890-5096(16)30757-9. doi: 10.1016/j.avsg.2017.01.010. [Epub ahead of print] Review.

PMID:
28390916
8.

Edoxaban: Defining place in therapy for the newest direct acting oral anticoagulant.

Gibson CM, Finks SW.

Am J Med. 2017 Apr 5. pii: S0002-9343(17)30342-X. doi: 10.1016/j.amjmed.2017.02.048. [Epub ahead of print] Review.

PMID:
28390791
9.

[Edoxaban (LIXIANA®) : new oral anticoagulant forthetreatment and secondary prevention of thromboembolic disease].

Scheen AJ, Lancellotti P.

Rev Med Liege. 2016 Nov;71(11):517-524. Review. French.

PMID:
28387109
10.

Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.

Cheung KS, Leung WK.

World J Gastroenterol. 2017 Mar 21;23(11):1954-1963. doi: 10.3748/wjg.v23.i11.1954. Review.

11.

Heparin-bridging therapy and risk of post-polypectomy bleeding: A meta-analysis of data reported by Japanese colonoscopists.

Jaruvongvanich V, Assavapongpaiboon B, Wijarnpreecha K, Ungprasert P.

Dig Endosc. 2017 Mar 31. doi: 10.1111/den.12882. [Epub ahead of print] Review.

PMID:
28370508
12.

Stent technology in ischemic stroke.

Yoon NK, Awad AW, Kalani MY, Taussky P, Park MS.

Neurosurg Focus. 2017 Apr;42(4):E11. doi: 10.3171/2017.1.FOCUS16507. Review.

PMID:
28366059
13.

Management of Anticoagulants and Antiplatelet Agents During Colonoscopy.

Feagins LA.

Am J Med. 2017 Mar 24. pii: S0002-9343(17)30244-9. doi: 10.1016/j.amjmed.2017.01.052. [Epub ahead of print] Review.

PMID:
28344132
14.

Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence.

Bo M, Grisoglio E, Brunetti E, Falcone Y, Marchionni N.

Eur J Intern Med. 2017 Mar 24. pii: S0953-6205(17)30116-4. doi: 10.1016/j.ejim.2017.03.012. [Epub ahead of print] Review.

PMID:
28343849
15.

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide.

Del Re M, Fogli S, Derosa L, Massari F, De Souza P, Crucitta S, Bracarda S, Santini D, Danesi R.

Cancer Treat Rev. 2017 Apr;55:71-82. doi: 10.1016/j.ctrv.2017.03.001. Epub 2017 Mar 9. Review.

PMID:
28340451
16.

Pathogenesis and management of antiphospholipid syndrome.

Arachchillage DR, Laffan M.

Br J Haematol. 2017 Mar 24. doi: 10.1111/bjh.14632. [Epub ahead of print] Review.

PMID:
28339096
17.

Reversing the anticoagulation effects of dabigatran.

Dager WE, Banares L.

Hosp Pract (1995). 2017 Apr;45(2):29-38. doi: 10.1080/21548331.2017.1298389. Epub 2017 Mar 24. Review.

PMID:
28335637
18.

Perioperative Considerations and Management of Patients Receiving Anticoagulants.

Shaikh SI, Kumari RV, Hegade G, Marutheesh M.

Anesth Essays Res. 2017 Jan-Mar;11(1):10-16. doi: 10.4103/0259-1162.179313. Review.

19.

Reintroduction of anti-thrombotic therapy after a gastrointestinal haemorrhage: if and when?

Scott MJ, Veitch A, Thachil J.

Br J Haematol. 2017 Apr;177(2):185-197. doi: 10.1111/bjh.14599. Epub 2017 Mar 8. Review.

PMID:
28272736
20.

Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence.

Russo V, Rago A, Proietti R, Di Meo F, Antonio Papa A, Calabrò P, D'Onofrio A, Nigro G, AlTurki A.

Ther Adv Drug Saf. 2017 Feb;8(2):67-75. doi: 10.1177/2042098616673990. Epub 2016 Oct 24. Review.

Supplemental Content

Loading ...
Support Center